Trial Condition(s):
Neoplastic CNS lesions
Contrast Enhanced MRI of the CNS - Patients with known cerebral neoplastic lesions.
Bayer Identifier:
91780
ClinicalTrials.gov Identifier:
EudraCT Number:
EU CT Number:
Not Available
Trial Purpose
Study to compare of two contrast agents in imaging brain lesions.
Inclusion Criteria
: - Known neoplastic CNS lesions
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
Trial Dates
Phase
Could I receive a placebo?
Products
Accepts Healthy Volunteers
Where to Participate
| Locations | |
|---|---|
Locations Investigative Site Novara, Italy, 28100 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Verona, Italy, 37126 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Napoli, Italy, 80131 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Trieste, Italy, 34149 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Barletta-Andria-Trani, Italy, 70031 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Milano, Italy, 20132 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Roma, Italy, 00168 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Chieti, Italy, 66100 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Catania, Italy, 95126 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Messina, Italy, 98125 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Siena, Italy, 53100 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Roma, Italy, 00133 | Contact Us: E-mail: [email protected] Phone: Not Available |
Trial Design
Contrast-enhanced MRI examination of cerebral neoplastic enhancing lesions: comparison of diagnostic efficacy of Gd-DOTA 0.5M and Gadobutrol 1.0 M at 0.1 mmol/kg body weight: intraindividual comparison clinical study.
Trial Type:
Interventional
Intervention Type:
Drug
Trial Purpose:
Diagnostic
Allocation:
Randomized
Blinding:
Single Blind
Assignment:
Parallel Assignment
Trial Arms:
2
Primary Outcome
- The primary analysis will be the comparison of the enhancements characteristics of Gadobutrol and Gd-TOTA on a lesion per lesion basis.Timeframe: October 2007 to November 2008
Additional Information
Copyright © Bayer
Powered by
